{
    "nctId": "NCT03008031",
    "briefTitle": "Reduced Contrast Administration in Contrast-enhanced Spectral Mammography (CESM)",
    "officialTitle": "N/A",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Neoplasm, Contrast-enhanced Spectral Mammography",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 11,
    "primaryOutcomeMeasure": "Accuracy of maximum tumor size measurements for breast cancer detected with the clinical CESM exam (reference) compared to the (experimental) CESM exams with varying (lower) dose concentrations.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patient with histopathologically confirmed invasive breast cancer who recently underwent a clinical CESM exam without complications;\n* Treated with primary surgery;\n* Willing and able to undergo all study procedures;\n* Has personally provided written informed consent.\n* Age \u2265 18\n\nExclusion Criteria:\n\n* Pregnancy\n* Allergy for any of the ingredients of (Ultravist) contrast agent\n* Being unable to give informed consent in person\n* History of coronary arterial disease or unstable angina\n* Acute or chronic severe renal insufficiency",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}